Form 4: Axon Enterprise CPO & CTO Jeffrey Kunins Reports Acquisition of 41,236 Shares

Sentiment:

SEC Form 4 Filing


Axon Enterprise's CPO & CTO, Jeffrey Kunins, reports acquiring 41,236 shares of common stock and discloses details regarding performance-based restricted stock units.

Summary

  • On March 24, 2025, Jeffrey C. Kunins, CPO & CTO of Axon Enterprise, Inc., reported acquiring 41,236 shares of common stock.
  • The acquisition was related to performance-based restricted stock units granted on December 22, 2023, under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
  • The performance conditions for tranches 1 and 2 were certified by the Compensation Committee on the transaction date.
  • Tranche 1 will vest on June 2, 2025, and tranche 2 will vest on December 1, 2025, subject to continued employment.
  • Following vesting, shares are subject to a minimum holding period until the earlier of December 31, 2030, or the vesting date of a subsequent tranche, excluding shares withheld for taxes.
  • After the transaction, Kunins beneficially owns 165,479 shares of Axon Enterprise, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction, but the acquisition of shares by a key executive can be interpreted as a sign of confidence in the company's prospects.

Positives

  • The acquisition of shares by a key executive like the CPO & CTO could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document outlines the vesting schedule and holding period for the restricted stock units, indicating a long-term commitment from the executive.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Axon Enterprise.

Comparison to Industry Standards

  • Stock-based compensation is a common practice in the technology industry to incentivize and retain key executives.
  • Vesting schedules and holding periods are standard features of restricted stock unit agreements, aligning executive interests with long-term shareholder value.
  • Companies like Palantir, Crowdstrike, and Datadog also utilize stock-based compensation as part of their overall compensation strategy.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates

DateDescription
December 22, 2023Date of grant for performance-based restricted stock units under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
March 24, 2025Date of transaction: Acquisition of 41,236 shares of common stock.
March 26, 2025Date of signature for the Form 4 filing.
June 2, 2025Vesting date for tranche 1 of the restricted stock units.
December 1, 2025Vesting date for tranche 2 of the restricted stock units.
December 31, 2030End date of the minimum holding period for vested shares, if no subsequent tranche vests earlier.

Keywords

Axon Enterprise, Jeffrey Kunins, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Plan, CPO, CTO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.